PRDS
Income statement / Annual
Last year (2022), Pardes Biosciences, Inc.'s total revenue was $0.00,
and the percentage change from the previous year is not available.
In 2022, Pardes Biosciences, Inc.'s net income was -$93.45 M.
See Pardes Biosciences, Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2022
|
FY-2021
|
| Period Ended |
12/31/2022 |
12/31/2021 |
| Operating Revenue |
$0.00 |
$0.00 |
| Cost of Revenue |
$0.00
|
$0.00
|
| Gross Profit |
$0.00
|
$0.00
|
| Gross Profit Ratio |
0
|
0
|
| Research and Development Expenses |
$70.35 M
|
$28.15 M
|
| General & Administrative Expenses |
$29.47 M
|
$10.34 M
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$29.47 M
|
$10.34 M
|
| Other Expenses |
$0.00
|
$0.00
|
| Operating Expenses |
$99.82 M
|
$38.49 M
|
| Cost And Expenses |
$99.82 M
|
$38.49 M
|
| Interest Income |
$0.00
|
$0.00
|
| Interest Expense |
$3.18 M
|
$30.00 K
|
| Depreciation & Amortization |
$0.00
|
$236.56 K
|
| EBITDA |
-$93.45 M |
$38.72 M |
| EBITDA Ratio |
0
|
0
|
| Operating Income Ratio |
0
|
0
|
| Total Other Income/Expenses Net |
$0.00
|
-$30.00 K
|
| Income Before Tax |
-$96.63 M
|
$0.00
|
| Income Before Tax Ratio |
0
|
0
|
| Income Tax Expense |
-$3.18 M
|
$30.00 K
|
| Net Income |
-$93.45 M
|
-$38.55 M
|
| Net Income Ratio |
0
|
0
|
| EPS |
-1.61 |
-0.68 |
| EPS Diluted |
-1.61 |
-0.68 |
| Weighted Average Shares Out |
$58.13 M
|
$56.90 M
|
| Weighted Average Shares Out Diluted |
$58.13 M
|
$56.90 M
|
| Link |
|
|
